FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224951192> ?p ?o ?g. }

• W4224951192 abstract "Methyltransferase-like 3 ( METTL3 ) is an RNA methyltransferase mediating N6 methyladenosine (m6A) modification. Its role in cancer pathogenesis and progression has attracted increasing attention. However, the immunological role, possible immune mechanism, and clinical significance of METTL3 in esophageal squamous cell carcinoma (ESCC) remain to be confirmed. The Tumor Genome Atlas (TCGA) provided clinical and transcriptome sequencing data for this study (162 tumor tissue samples and 11 normal tissue samples), while the Immunology Database and Analysis Portal (immport, https://www.immport.org/home ) provided 2483 immune-related genes. METTL3 was substantially expressed in ESCC and linked to poor prognosis in ESCC, according to the findings. Functional analysis revealed that METTL3 is mainly involved in chromosomal homologous recombination and DNA mismatch repair processes, which could be potential mechanisms for tumor disease development and progression. Analysis on the TISIDB website shows that effector memory CD8 T cells, NK cells, neutrophils and other cells are highly correlated with METTL3 expression. We screened immune genes associated with METTL3 by Spearman’s analysis and performed functional analysis. These immune genes were mostly linked with immune processes, such as cytokine receptors, the MAPK signaling pathway, and natural killer cell-mediated cytotoxicity, indicating that METTL3 is a key molecule in the immune regulation of esophageal cancer. In addition, based on METTL3 -related immune genes, we separated the patients into several subgroups and constructed a prognostic prediction model consisting of six immune genes. As an independent prognostic indicator for ESCC, the risk score of this model can be employed. A nomogram was also developed to accurately evaluate individual prognoses based on clinical indicators and risk scores. In summary, this study suggests that METTL3 is not only a potential pathogenic molecule for esophageal carcinogenesis and progression but also a potential biological marker for forecasting ESCC patient prognosis and could serve as a basis for clinical decision making." @default.
• W4224951192 created "2022-04-28" @default.
• W4224951192 creator A5011794788 @default.
• W4224951192 creator A5034063062 @default.
• W4224951192 creator A5036655050 @default.
• W4224951192 creator A5054059790 @default.
• W4224951192 creator A5056842955 @default.
• W4224951192 creator A5073632725 @default.
• W4224951192 creator A5089596894 @default.
• W4224951192 date "2022-04-27" @default.
• W4224951192 modified "2023-10-01" @default.
• W4224951192 title "METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker" @default.
• W4224951192 cites W1492564057 @default.
• W4224951192 cites W1566952502 @default.
• W4224951192 cites W1592095850 @default.
• W4224951192 cites W1634699770 @default.
• W4224951192 cites W1985987855 @default.
• W4224951192 cites W1990827580 @default.
• W4224951192 cites W1995144762 @default.
• W4224951192 cites W1998767819 @default.
• W4224951192 cites W2009216661 @default.
• W4224951192 cites W2025240091 @default.
• W4224951192 cites W2027895157 @default.
• W4224951192 cites W2028140166 @default.
• W4224951192 cites W2029799473 @default.
• W4224951192 cites W2059221230 @default.
• W4224951192 cites W2078941094 @default.
• W4224951192 cites W2091415498 @default.
• W4224951192 cites W2091724447 @default.
• W4224951192 cites W2095237346 @default.
• W4224951192 cites W2115462905 @default.
• W4224951192 cites W2130006273 @default.
• W4224951192 cites W2130410032 @default.
• W4224951192 cites W2147494386 @default.
• W4224951192 cites W2150026213 @default.
• W4224951192 cites W2153505392 @default.
• W4224951192 cites W2272984102 @default.
• W4224951192 cites W2295124130 @default.
• W4224951192 cites W2311746741 @default.
• W4224951192 cites W2327517543 @default.
• W4224951192 cites W2403874820 @default.
• W4224951192 cites W2559588208 @default.
• W4224951192 cites W2574912984 @default.
• W4224951192 cites W2604808360 @default.
• W4224951192 cites W2627064270 @default.
• W4224951192 cites W2749884966 @default.
• W4224951192 cites W2756398555 @default.
• W4224951192 cites W2781525129 @default.
• W4224951192 cites W2788142646 @default.
• W4224951192 cites W2792468812 @default.
• W4224951192 cites W2805162488 @default.
• W4224951192 cites W2829377719 @default.
• W4224951192 cites W2889646458 @default.
• W4224951192 cites W2892764673 @default.
• W4224951192 cites W2900569176 @default.
• W4224951192 cites W2905199685 @default.
• W4224951192 cites W2937441321 @default.
• W4224951192 cites W2943265561 @default.
• W4224951192 cites W2944485914 @default.
• W4224951192 cites W2947674709 @default.
• W4224951192 cites W2952293896 @default.
• W4224951192 cites W2990016380 @default.
• W4224951192 cites W2990256362 @default.
• W4224951192 cites W2994346287 @default.
• W4224951192 cites W2996828470 @default.
• W4224951192 cites W3010015158 @default.
• W4224951192 cites W3012716831 @default.
• W4224951192 cites W3013078623 @default.
• W4224951192 cites W3016541254 @default.
• W4224951192 cites W3021935763 @default.
• W4224951192 cites W3025271696 @default.
• W4224951192 cites W3037477427 @default.
• W4224951192 cites W3041057889 @default.
• W4224951192 cites W3041905456 @default.
• W4224951192 cites W3044496248 @default.
• W4224951192 cites W3081921226 @default.
• W4224951192 cites W3088016495 @default.
• W4224951192 cites W3093354952 @default.
• W4224951192 cites W3107527779 @default.
• W4224951192 cites W3154997285 @default.
• W4224951192 cites W3162016599 @default.
• W4224951192 cites W3165331125 @default.
• W4224951192 cites W3165427881 @default.
• W4224951192 cites W3175783747 @default.
• W4224951192 cites W3184193618 @default.
• W4224951192 cites W3186848081 @default.
• W4224951192 cites W3197718606 @default.
• W4224951192 cites W3204376221 @default.
• W4224951192 cites W3209732115 @default.
• W4224951192 cites W4210685329 @default.
• W4224951192 doi "https://doi.org/10.3389/fonc.2022.824190" @default.
• W4224951192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35574315" @default.
• W4224951192 hasPublicationYear "2022" @default.
• W4224951192 type Work @default.
• W4224951192 citedByCount "6" @default.
• W4224951192 countsByYear W42249511922022 @default.
• W4224951192 countsByYear W42249511922023 @default.
• W4224951192 crossrefType "journal-article" @default.
• W4224951192 hasAuthorship W4224951192A5011794788 @default.
• W4224951192 hasAuthorship W4224951192A5034063062 @default.

• next